A Cost-Effectiveness Analysis of PCV21 Use in Vaccine-Experienced Adults Aged ≥65 Years in the U.S.

American Journal of Preventive Medicine 2026

View at publisher

Authors: Zinan Yi, Kwame Owusu‐Edusei, Elamin H. Elbasha

DOI: 10.1016/j.amepre.2026.108303

Cited by: 0

References: 31

Fields of Study & Subjects

Pneumonia and Respiratory Infections Health Systems Economic Evaluations Quality of Life Bacterial Infections and Vaccines

References 31